HeartLogic™ Heart Failure Diagnostic
Learn how HeartLogic works and how it’s advanced the way clinicians care for heart failure patients.
For health care professionals in EUROPE except those practicing in France as the following pages are intended to all International health care professionals and are not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Other health care professionals should select their country in the top right corner of the website.
Please note that the following pages are exclusively reserved for health care professionals in countries with applicable health authority product registrations. To the extent this site contains information, reference guides and databases intended for use by licensed medical professionals, such materials are not intended to offer professional medical advice. Prior to use, please consult device labeling for prescriptive information and operating instructions.
This Website is protected by the laws on copyright and by the relevant international conventions. It is strictly forbidden to make copies, whether partial or total and on whichever media without prior approval.
Learn how HeartLogic works and how it’s advanced the way clinicians care for heart failure patients.
The launch of HeartLogic really represents a completely new era in how we use implantable devices to help patients, to help the healthcare system…It really changes the landscape entirely.”
Kenneth Stein, MD, FACC, FHRS
Our Multiple Sensors. Your Sixth Sense.
The HeartLogic Heart Failure Diagnostic uses multiple sensors to track physiological trends, combines them into one composite index and sends a proactive alert of potential worsening heart failure¹.
References
1. Boehmer JP, Hariharan R, Devecchi FG, et al. A Multisensor algorithm predicts heart failure events in patients with implanted devices: results from the MultiSENSE study. JACC Heart Fail. 2017 Mar;5(3):216-25.
2. After Hospitalization: A Dartmouth Atlas Report on Post-Acute Care for Medicare Beneficiaries, Sept28th, 2011.
3. Fonarow GC, Abraham WT, Albert NM, et al. Association between performance measures and clinical outcomes for patients hospitalized with heart failure. J AMA. 2007;297(1):61–70. https://www.ncbi.nlm.nih.gov/pubmed/17200476.
4. O’Connor CM, Abraham WT, Albert NM, et al. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J. 2008
5. https://circ.ahajournals.org/content/123/8/933?ijkey=ef69d682d9a0210be678bba2f4bd7f3bac3b1239&keytype2=f_ipsecsha
6. National Institute of Health and Care Excellence. NICE guidance DG72, Heart failure algorithms for remote monitoring in people with cardiac implantable electronic devices, Updated External Assessment Report (dated 20 March 2024), produced by Newcastle Technology Assessment Review Group, Newcastle University, published as part of committee papers, 14 May 2024.
CAUTION:
The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labelling supplied with each device. Information for use only in countries with applicable health authority registrations. Material not intended for use in France.
All cited trademarks are the property of their respective owners.